Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVE
Aya Awwad(Harvard University), Gerald S. Bloomfield, Carl J. Fichtenbaum(Cancer Research And Biostatistics), Sarah M Chu(Harvard University), Kara W Chew, Craig A. Sponseller, Amy Shirong Lu(Harvard University), Shashwatee Bagchi(Washington University in St. Louis), Pamela S. Douglas(Duke University), Sophia Zhao(Harvard University), Markella V. Zanni(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Michael T. Lu(Cancer Research And Biostatistics), Graham Smith, Christopher R. deFilippi, Carlos Malvestutto(The Ohio State University Wexner Medical Center), Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Celestine N. Wanjalla(VA Tennessee Valley Healthcare System), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k